Pramipexole
Back to searchMolecule Structure
Scientific Name
Pramipexole
Description of the Drug
Pramipexole is a non-ergot dopamine agonist used to treat the signs and symptoms of idiopathic Parkinson’s disease and Restless Legs Syndrome (RLS).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00413
http://www.drugbank.ca/drugs/DB00413
Brand Name(s)
Mirapexin, Neliprax, Oprymea, Pipexus
Company Owner(s)
Xiamen Lp Pharmacuetical Co Ltd, Sun Pharmaceutical Industries Inc, Macleods Pharmaceuticals Ltd, Anchen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Torrent Pharmaceuticals Ltd, Graviti Pharmaceuticals Private Ltd, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc, Boehringer Ingelheim Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | AGONIST | CHEMBL2331075 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL35376 | ||
| Human Metabolome Database | HMDB0014557 | ||
| DrugBank | DB00413 | ||
| PubChem: Thomson Pharma | 14797724 | 14748917 | |
| PubChem | 119570 | ||
| Mcule | MCULE-1323845397 | ||
| LINCS | LSM-5243 | ||
| Nikkaji | J419.937E | ||
| PDBe | G6L | ||
| BindingDB | 50116766 | ||
| EPA CompTox Dashboard | DTXSID6023496 | ||
| DrugCentral | 2233 | ||
| ChemicalBook | CB0486178 | ||
| Guide to Pharmacology | 953 | ||
| rxnorm | PRAMIPEXOLE | PRAMIPEXOLE DIHYDROCHLORIDE | MIRAPEX |
| ChEBI | 8356 | ||
| ZINC | ZINC000003781664 |
